As of the latest SEC filings, Trevi Therapeutics, Inc. (TRVI) is held by 166 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $44,129,821.59 in market value, representing a significant portion of its portfolio.
Funds holding Trevi Therapeutics, Inc. (TRVI)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- TRVI
- CIK:
- 0001563880
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $44,129,821.59 | 3,699,063 | Mar 31, 2026 | May 28, 2026 |
|
ETAHX
Eventide Healthcare & Life Sciences Fund
|
MF | Independent / Boutique | 1.97% | $31,284,110.58 | 2,622,306 | Mar 31, 2026 | May 29, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.04% | $27,803,425.71 | 2,330,547 | Mar 31, 2026 | May 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.51% | $27,278,741.20 | 2,288,485 | Feb 28, 2026 | Apr 24, 2026 |
|
FIDGX
Fidelity Small Cap Growth Fund
|
MF | Fidelity | 0.32% | $26,836,692.16 | 1,950,341 | Apr 30, 2026 | Jun 26, 2026 |
|
QUAZX
AB Small Cap Growth Portfolio
|
MF | Independent / Boutique | 0.56% | $16,502,299.20 | 1,199,295 | Apr 30, 2026 | Jun 24, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.02% | $13,864,210.90 | 1,162,130 | Mar 31, 2026 | May 28, 2026 |
|
FOCSX
Fidelity Small Cap Growth K6 Fund
|
MF | Fidelity | 0.32% | $13,623,239.36 | 990,061 | Apr 30, 2026 | Jun 26, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.04% | $13,014,662.08 | 945,833 | Apr 30, 2026 | Jun 26, 2026 |
|
FSPHX
Select Health Care Portfolio
|
MF | Fidelity | 0.19% | $11,920,000.00 | 1,000,000 | Feb 28, 2026 | Apr 24, 2026 |
|
PGRTX
SmallCap Growth Fund I
|
MF | Independent / Boutique | 0.47% | $11,050,986.24 | 803,124 | Apr 30, 2026 | Jun 25, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.08% | $9,315,373.48 | 780,836 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.09% | $7,259,178.33 | 608,481 | Mar 31, 2026 | May 28, 2026 |
|
FFGRX
Emerald Growth Fund
|
MF | Independent / Boutique | 0.51% | $7,225,541.12 | 525,112 | Apr 30, 2026 | Jun 22, 2026 |
|
BDSKX
BlackRock Advantage Small Cap Core Fund
|
MF | BlackRock / iShares | 0.15% | $6,904,600.40 | 579,245 | Feb 27, 2026 | Apr 24, 2026 |
|
FACTX
Fidelity Advisor Health Care Fund
|
MF | Fidelity | 0.24% | $6,880,000.00 | 500,000 | Apr 30, 2026 | Jun 26, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.02% | $6,472,154.72 | 542,966 | Feb 28, 2026 | Apr 24, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.03% | $5,968,510.88 | 500,714 | Feb 28, 2026 | Apr 24, 2026 |
|
XPH
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
|
ETF | State Street (SPDR) | 1.92% | $5,898,573.76 | 494,432 | Mar 31, 2026 | May 28, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.04% | $5,363,165.60 | 449,930 | Feb 28, 2026 | Apr 28, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.01% | $4,480,728.00 | 375,900 | Feb 28, 2026 | Apr 24, 2026 |
|
FSCRX
Fidelity Small Cap Discovery Fund
|
MF | Fidelity | 0.18% | $3,951,872.00 | 287,200 | Apr 30, 2026 | Jun 26, 2026 |
|
FJACX
Fidelity Series Small Cap Discovery Fund
|
MF | Fidelity | 0.18% | $3,473,024.00 | 252,400 | Apr 30, 2026 | Jun 26, 2026 |
|
IHE
iShares U.S. Pharmaceuticals ETF
|
ETF | BlackRock / iShares | 0.35% | $3,463,350.58 | 290,306 | Mar 31, 2026 | May 22, 2026 |
|
FZAOX
Fidelity Advisor Small Cap Fund
|
MF | Fidelity | 0.15% | $3,331,640.00 | 279,500 | Feb 28, 2026 | Apr 24, 2026 |
Advertisement (320x50)